share_log

MSSV's Global Stem Cells Group Announces Launch of New Stem Cells and Regenerative Medicine Clinic in CDMX

MSSV's Global Stem Cells Group Announces Launch of New Stem Cells and Regenerative Medicine Clinic in CDMX

MSSV 全球幹細胞小組宣佈在 CDMX 推出新的幹細胞和再生醫學診所
GlobeNewswire ·  2022/10/28 19:07

Global Stem Cells Group in Mexico City

墨西哥城全球幹細胞組織

Global Stem Cells Group in Mexico City
墨西哥城全球幹細胞組織

LAS VEGAS, NV, Oct. 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Meso Numismatics, Inc. ("Meso Numismatics" or the "Company") (MSSV), a technology company specializing in Biotech and Numismatics, announces a new partnership that enhances Global Stem Cells Group's goal of establishing its therapies and technology to meet market demand in populated areas of the world.

內華達州拉斯維加斯,2022年10月28日(Global Newswire)-通過NewMediaWire-Meso Numismatics,Inc.(“Meso Numismatics”或“公司”)(MSSV),一家專門從事生物技術和貨幣學的技術公司,宣佈建立新的合作伙伴關係,加強全球幹細胞組織的其目標是建立其療法和技術,以滿足世界人口稠密地區的市場需求。

This collaboration with STEM LIFE clinic's new facility and Dr. Vanessa Rodriguez Pares, currently one of the most prestigious aesthetic clinics in Mexico City, is expected to promote a high level of service in regenerative medicine throughout the country.

此次與幹細胞生命診所新設施和瓦內薩·羅德里格斯·帕雷斯博士目前是墨西哥城最負盛名的美容診所之一,預計將在全國推廣高水平的再生醫學服務。

As part of this effort, the International Society for the Application of Stem Cells (ISSCA) has granted an affiliation and the use of their brand, products, therapies, and training on how to apply stem cell therapies to Dr. Vanessa Rodriguez Peers.

作為這一努力的一部分,國際幹細胞應用學會(ISSCA)已批准加入並使用他們的品牌、產品、療法,以及如何將幹細胞療法應用於Vanessa Rodriguez博士同行的培訓。

"This new partnership aims to expand the Global Stem Cells Group (GSCG) brand and create centers of excellence in cell therapy to meet the high demand in the Mexican market," said Benito Novas, CEO of Global stem cells group "GSCG is rapidly expanding its global operations as it seeks to become a major player in the lucrative regenerative medicine industry. To achieve our expansion plans, our organization is partnering with healthcare providers specializing in regenerative medicine with at least five years of experience in the healthcare sector."

這一新的合作伙伴關係旨在擴大全球幹細胞集團(GSCG)的品牌,並創建卓越的細胞治療中心,以滿足墨西哥市場的高需求。貝尼託·諾瓦斯,全球幹細胞集團首席執行官GSCG正在迅速擴大其全球業務,以期成為利潤豐厚的再生醫學行業的主要參與者。為了實現我們的擴張計劃,我們的組織正在與專門從事再生醫學的醫療保健提供者合作,這些提供者在醫療保健領域至少有五年的經驗。

We believe stem cell therapy is becoming an increasingly effective clinical solution for treating conditions that traditional or conventional medicine only offers within palliative care and pain management. Patients around the world are seeking a natural regenerative alternative without the potential risks and side effects sometimes associated with conventional pharmaceuticals.

我們相信,幹細胞療法正在成為一種日益有效的臨牀解決方案,用於治療傳統或傳統醫學只能在姑息治療和疼痛控制範圍內提供的疾病。世界各地的患者都在尋求一種天然的再生替代品,而不會出現傳統藥物有時會帶來的潛在風險和副作用。

The opening of this center, which will include the construction of an autologous tissue processing laboratory and an allogeneic tissue bank, is expected to help transition stem cell therapies and regenerative medicines from being an elective procedure to being accessible to patients throughout Mexico.

該中心的開業將包括建設一個自體組織處理實驗室和一個同種異體組織庫,預計將有助於將幹細胞治療和再生藥物從一種可選程序過渡到墨西哥各地的患者可以獲得。

About Dr. Vanessa Rodriguez Pares

關於Vanessa Rodriguez Pares博士

Dr. Vanessa Rodriguez Pares is a specialist in aesthetic medicine and surgery, with special attention to obesity and overweight in all ages. She is an expert in management of cosmetic surgery with a comprehensive approach to the patient, taking into account their safety and their physical, psychological, and emotional needs, as well as a specialist in ULTHERAPY treatment to perform facelift without surgery. In addition to extensive experience with cellular therapies and regenerative medicine since 2016, she specializes in anti-aging techniques, hair regeneration, and facial aesthetics with stem cell assisted lipotransfer, among other techniques.

Vanessa Rodriguez Pares博士是美容醫學和外科的專家,特別關注所有年齡段的肥胖和超重。她是整容手術管理的專家,對患者採取全面的方法,考慮到他們的安全性以及他們的身體、心理和情感需求,以及在不做手術的情況下進行面部除皺的Ultreation治療方面的專家。自2016年以來,除了在細胞療法和再生醫學方面擁有豐富的經驗外,她還擅長抗衰老技術、頭髮再生和幹細胞輔助脂肪轉移的面部美容等技術。

About Global Stem Cells Group

關於全球幹細胞集團

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products, and solutions.

全球幹細胞集團是六家全資運營公司的母公司,完全致力於幹細胞研究、培訓、產品和解決方案。

Founded in 2012, the company combines dedicated researchers, physician and patient educators, and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine Global Stem Cells Group's corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG's six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

該公司成立於2012年,將敬業的研究人員、醫生和患者教育工作者以及解決方案提供商結合在一起,共同實現滿足全球對尖端幹細胞治療和解決方案日益增長的需求的目標。全球幹細胞集團及其子公司專注於這一令人興奮的新醫學研究領域,處於獨特的地位,有望成為細胞醫學領域的全球領先者。全球幹細胞集團的企業使命是為世界各地的患者實現幹細胞醫學的承諾。GSCG的六家運營公司中的每一家都專注於獨立的研究任務,結果是形成了一個最先進的幹細胞治療全球網絡。

Global Stem Cells Group is a publicly traded company operating under the symbol MSSV.

全球幹細胞集團是一家上市公司,代碼為MSSV。

To learn more about Global Stem Cells Group, Inc.'s companies visit our website

欲瞭解有關全球幹細胞集團公司的更多信息,請訪問我們的網站

or call +1 305 560 5331

或致電+1 305 560 5331

Forward-Looking Statements

前瞻性陳述

Some information in this document constitutes forward-looking statements or statements which may be deemed or construed to be forward-looking statements, such as the closing of the share exchange agreement. The words "plan", "forecast", "anticipates", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in the Company's filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Meso Numismatics, Inc., herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Meso Numismatics, Inc. disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.

本文件中的一些信息構成前瞻性陳述,或可能被視為或被解釋為前瞻性陳述,例如股票交換協議的結束。“計劃”、“預測”、“預期”、“估計”、“項目”、“打算”、“預期”、“應該”、“相信”等詞語以及類似的表述旨在識別前瞻性陳述。這些前瞻性陳述涉及並受制於已知和未知的風險、不確定性和其他因素,這些風險、不確定性和其他因素可能導致公司的實際結果、業績(財務或經營)或成就與這些前瞻性陳述明示或暗示的未來結果、業績(財務或經營)或成就不同。風險、不確定性和其他因素在該公司提交給美國證券交易委員會的文件中得到了更充分的討論。本新聞稿中可歸因於Meso Numismatics公司的所有前瞻性陳述均受上述警告性聲明的明確限制。除非法律要求,Meso Numismatics公司不承擔更新本估計中包含的前瞻性陳述的任何義務。

For further information, please contact:
investor.relations@mssvinc.com
Telephone: (800) 956-3935

如需更多信息,請聯繫:
郵箱:investor.relationship@mssvinc.com
電話:(800)956-3935

Attachment

依附

  • Global Stem Cells Group in Mexico City
  • 墨西哥城全球幹細胞組織

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論